Literature DB >> 17940943

Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.

Robert Colebunders1, Antoine Tshomba, Maria D Van Kerkhove, Daniel G Bausch, Pat Campbell, Modeste Libande, Patricia Pirard, Florimond Tshioko, Simon Mardel, Sabue Mulangu, Hilde Sleurs, Pierre E Rollin, Jean-Jacques Muyembe-Tamfum, Benjamin Jeffs, Matthias Borchert.   

Abstract

The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the quality of clinical documentation. Surveillance and clinical records of 77 patients with MHF cases were reviewed. Initial symptoms included fever, headache, general pain, nausea, vomiting, and anorexia (median day of onset, day 1-2), followed by hemorrhagic manifestations (day 5-8+), and terminal symptoms included confusion, agitation, coma, anuria, and shock. Treatment in isolation wards was acceptable, but the quality of clinical documentation was unsatisfactory. Improved clinical documentation is necessary for a basic evaluation of supportive treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17940943     DOI: 10.1086/520543

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.

Authors:  John Misasi; Kartik Chandran; Jin-Yi Yang; Bryden Considine; Claire Marie Filone; Marceline Côté; Nancy Sullivan; Giulia Fabozzi; Lisa Hensley; James Cunningham
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

2.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

3.  Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances.

Authors:  Gordian Schudt; Larissa Kolesnikova; Olga Dolnik; Beate Sodeik; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

4.  Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Authors:  Veronica V Nicholas; Rebecca Rosenke; Friederike Feldmann; Dan Long; Tina Thomas; Dana P Scott; Heinz Feldmann; Andrea Marzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

5.  Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.

Authors:  Paul Roddy; Sara L Thomas; Benjamin Jeffs; Pascoal Nascimento Folo; Pedro Pablo Palma; Bengi Moco Henrique; Luis Villa; Fernando Paixao Damiao Machado; Oscar Bernal; Steven M Jones; James E Strong; Heinz Feldmann; Matthias Borchert
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 6.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

Review 7.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

8.  Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.

Authors:  Robert W Cross; Karla A Fenton; Joan B Geisbert; Hideki Ebihara; Chad E Mire; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

9.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

Review 10.  Clinical management of filovirus-infected patients.

Authors:  Danielle V Clark; Peter B Jahrling; James V Lawler
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.